trans
press release
trans
contact
impressum
legal notice
print this page
BioSolveIT
The Premier Scientific Solution Provider
Information Related to Recent Tripos Announcements
Premier cheminformatics software supplier BioSolveIT continues to offer support to ALL users of FlexX/S software.

St. Augustin, Nov 23rd, 2006    Due to a recent announcement related to the former distributor of BioSolveIT-products Tripos®, BiosolveIT would like to dispel any confusion about customer support. The FlexX/S suite of programs, also known for example as modules within SYBYL® is developed, owned, and is exclusively distributed by BioSolveIT.

In addition to supporting the directly licensed customers BiosolveIT will continue to support ALL users of BioSolveIT software; therefore ALL users can take advantage of BioSolveIT's premium support. If users have any concerns or questions regarding any of these matters they should please contact support@biosolveit.com.

The company says that continuous support of all existing platforms used to access FlexX is becoming more diverse. In addition, access to the well-established and extensively validated FlexX suite of programs will soon be possible within MOE® and from a new stand-alone FlexX GUI. Customers interested in viewing and testing early versions of these innovative ways of accessing FlexX are encouraged to write to license@biosolveit.com.

About BioSolveIT GmbH
BioSolveIT, the developer of FlexX, is a globally operating cheminformatics and bioinformatics software company. BioSolveIT provides superior custom software solutions for structure-based design, flexible molecular alignment, database searching, library design, and analysis. Its breakthrough computational technologies help to innovate pharmaceutical research — transforming ideas into success stories.
Press contact
Dr. Marcus Gastreich
BioSolveIT GmbH
An der Ziegelei 79
53757 St. Augustin
Germany
Phone: +49-2241-2525-0
Fax: +49-2241-2525-525

 

® All trademarks are the property of their respective owner
Last modified Thursday, 02. Feb 2012 23:19 CET by WebMaster